Cequent Pharmaceuticals Completes $9 Million Series A Financing with Equity Investment from Novartis Option Fund
Cequent Pharmaceuticals expands Scientific Leadership Team with Key Hires
02 May 2007
Cequent Pharmaceuticals tkRNAi Technology to be Presented at the RNAi-2007-Boston Meeting: RNA Interference: Biochemistry to Drugs & Therapeutics
13 April 2007
Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the American Association of Cancer Research Annual Meeting in Los Angeles
Cequent Pharmaceuticals, Inc. to Present February 27 at the Molecular Medicine Tri-Conference in San Francisco, CA.
